Skip to Main Content

Top of the morning to you, and a fine one it is. A shimmering sun and deliciously cool breeze are enveloping the Pharmalot campus, where one short person is sleeping in, another has left for gainful employment, and our official mascot is sniffing about. All of which is to say that conditions are just right for attacking our ever-growing to-do list. Perhaps you can relate to this task. If so, fire up your coffee kettle and join us for a cup of stimulation. Meanwhile, here are some tidbits to help you along. Hope you conquer the world today. …

President Trump is considering a sweeping executive order that would cut prices on virtually all brand-name medicines sold to Medicare and other government programs, according to Reuters. The order under discussion would be much broader than a previously disclosed proposal to lower prices on Part B drugs by tying prices to lower costs in other countries. The administration is now looking at ways to use this or a similar method to lower prices in Part D.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!